Honoring a legacy of product line reliability and strength, the SpectraMax Multi-Mode Microplate Readers have been transformed with next-generation innovation to improve research capabilities and provide unparalleled flexibility for a wide range of assays and applications.
SAN JOSE, Calif., July 15, 2025 /PRNewswire-PRWeb/ -- Molecular Devices, LLC., a leading high-performance life science solutions provider, today announced the launch of SpectraMax® iD5e and SpectraMax® iD3s Multi-Mode Microplate Readers. Honoring a legacy of product line reliability and strength, the SpectraMax Multi-Mode Microplate Readers have been transformed with next-generation innovation to improve research capabilities and provide unparalleled flexibility for a wide range of assays and applications.
"For over 40 years, our industry-leading microplate readers have empowered researchers to advance protein and cell biology, breaking barriers to novel discoveries," said Mary Duseau, President of Molecular Devices. "Our new SpectraMax iD5e and SpectraMax iD3s readers are designed to meet the evolving needs of modern laboratories, support the holistic exploration of cellular processes through advanced multi-omics research, and enable customers to push the boundaries of complex biology."
The SpectraMax iD5e and iD3s Multi-Mode Microplate Readers both offer tunable monochromator-based measurements with temperature control, making them ideal for researchers conducting absorbance, fluorescence, luminescence, and advanced detection assays. Common features include dual injectors with SmartInject® Technology for precise reagent mixing, as well as user-installable gas mixers and advanced shaking capabilities for live cell assays, providing flexibility and efficiency for diverse applications.
Microplate Reader Capabilities Compared
The SpectraMax iD3s reader was engineered for a streamlined design and affordability, making it ideal for labs seeking cost-effective solutions without compromising performance. The reader excels in performing ELISA, nucleic acid and protein quantitation, cell viability, and microbial assays. Its fully tunable monochromator wavelength selection offers assay flexibility, while optional upgrades—such as dual injection, advanced shaking, and environmental controls—enhance its versatility. The SpectraMax iD3s reader also features over 200 preconfigured protocols and a user-friendly interface, ensuring ease of use and enhanced productivity for various common assays.
The SpectraMax iD5e reader is an enhanced solution with hybrid optics, combining tunable monochromator and filter-based measurement capabilities. This reader is equipped to handle absorbance, fluorescence, luminescence, time-resolved fluorescence (TRF), and tunable fluorescence polarization (FP). Unique features of the SpectraMax iD5e reader include automatic filter identification using NFC functionality, western blot detection capabilities, and QuickSync data push technology for seamless data transfer. The microplate reader's flexible temperature control and intuitive touch screen interface make it ideal for busy, multi-user labs, ensuring reliable and high-performance results across an array of assays.
Intuitive Data Acquisition
SoftMax® Pro Software—the industry's most cited microplate reader software—powers both models and can be upgraded to a GxP version that assures full compliance with FDA and EudraLex guidelines. SoftMax Pro GxP Software streamlines workflows to optimize data integrity, analysis, and reporting, with secure, traceable electronic recordkeeping. Expert installation and validation services ensure operational specifications are met, supporting researchers in achieving reliable and compliant results.
The SpectraMax iD5e and iD3s microplate readers will be on display in booth #1407 at BioProcess International, September 15–18, 2025, Boston, Mass. Additional product information is available here.
About Molecular Devices, LLC.
Molecular Devices is one of the world's leading providers of high-performance bioanalytical measurement systems, software and consumables for life science research, pharmaceutical and biotherapeutic development. Included within a broad product portfolio are platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection. These leading-edge products enable scientists to improve productivity and effectiveness, ultimately accelerating research and the discovery of new therapeutics. Molecular Devices is committed to the continual development of innovative solutions for life science applications. The company is headquartered in Silicon Valley, California, with offices around the globe. For more information, please visit www.moleculardevices.com.
Media Contact
Amy Smith, Molecular Devices, 1 4083344699, [email protected], www.moleculardevices.com
SOURCE Molecular Devices
Share this article